GTranslate

Languages

Amsterdam 90-90-90 Targets (2018) PLHIV: 6,260

95%

94%

96%

Source: Provided by the City of Amsterdam

Amsterdam HIV Care Continuum (2018) PLHIV: 6,260

95%

91%

90%

86%

Source: Provided by the City of Amsterdam

The following counters and charts portray the current epidemiology of HIV. The charts have hovers and are changeable by clicking on them. They are also downloadable-see the download button.

6,260

Source: Provided by the City of Amsterdam

5,971

Source: Provided by the City of Amsterdam

5,683

Source: Provided by the City of Amsterdam

5,617

Source: Provided by the City of Amsterdam

5,379

Source: Provided by the City of Amsterdam

4,600

Source: Provided by the City of Amsterdam

4,436

Source: Provided by the City of Amsterdam

4,281

Source: Provided by the City of Amsterdam

4,240

Source: Provided by the City of Amsterdam

4,105

Source: Provided by the City of Amsterdam

147

Source: Provided by the City of Amsterdam

380

Source: Provided by the City of Amsterdam

395

Source: Provided by the City of Amsterdam

39

Source: Provided by the City of Amsterdam

Amsterdam

Hover your mouse on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2018 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2018 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2018. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2018. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2018, where people without a measurement in 2018 were considered unsuppressed.

Hover your mouse on bar for detailed data.

Methodology

The number of HIV-positive people by the end of 2018 was estimated by adding the total estimated number of people living with undiagnosed HIV to the observed number of diagnosed HIV-positive individuals living in Amsterdam, based on the first four digits of their most recent home address postal code. The number of undiagnosed people by the end of 2018 was estimated with the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool, using annual data on new HIV diagnoses stratified by CD4 count at the time of diagnosis or a concurrent AIDS diagnosis. This method reconstructed the number of annual newly acquired HIV infections and the distribution of time between infection and diagnosis, and subsequently determined the proportion still undiagnosed. Retention in care was defined as at least one clinic visit, or a CD4 or RNA measurement in 2018. People were considered to be on antiretroviral treatment whenever they started antiretroviral treatment before the end of 2018. Viral suppression was defined as HIV RNA <200 copies/ml at the last RNA measurement in 2018, where people without a measurement in 2018 were considered unsuppressed.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.

Hover on bar for detailed data.